| For Americans suffering from COVID-19 and seeking life-saving treatment, they may find themselves put on a waitlist depending on their skin color. The Food and Drug Administration, as well as multiple states, will prioritize race and ethnicity in determining who receives hard-to-get COVID-19 therapeutics. In some cases, even those with dangerous health conditions could be passed over for someone who is "non-white."
|
